Gateway Investment Advisers LLC Sells 25,714 Shares of Unum Group (NYSE:UNM)

Gateway Investment Advisers LLC cut its position in Unum Group (NYSE:UNM - Free Report) by 10.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 224,140 shares of the financial services provider's stock after selling 25,714 shares during the period. Gateway Investment Advisers LLC owned approximately 0.12% of Unum Group worth $16,369,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in UNM. Capital Performance Advisors LLP purchased a new position in Unum Group in the 3rd quarter worth about $31,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Unum Group in the third quarter worth approximately $37,000. V Square Quantitative Management LLC raised its holdings in shares of Unum Group by 38.2% during the third quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider's stock valued at $42,000 after purchasing an additional 194 shares during the last quarter. Versant Capital Management Inc lifted its position in Unum Group by 26.4% during the fourth quarter. Versant Capital Management Inc now owns 766 shares of the financial services provider's stock valued at $56,000 after purchasing an additional 160 shares during the period. Finally, William B. Walkup & Associates Inc. purchased a new stake in Unum Group in the second quarter worth approximately $44,000. Institutional investors own 86.57% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Wells Fargo & Company boosted their target price on shares of Unum Group from $74.00 to $81.00 and gave the company an "overweight" rating in a research note on Tuesday. Morgan Stanley raised their target price on Unum Group from $62.00 to $64.00 and gave the stock an "equal weight" rating in a research report on Wednesday, October 30th. UBS Group raised shares of Unum Group to a "hold" rating in a research report on Wednesday, October 9th. Barclays raised their price objective on shares of Unum Group from $76.00 to $85.00 and gave the stock an "overweight" rating in a report on Monday, January 6th. Finally, Piper Sandler upped their target price on shares of Unum Group from $74.00 to $82.00 and gave the company an "overweight" rating in a report on Wednesday, December 18th. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $75.45.

Unum Group Price Performance

Shares of Unum Group stock traded up $0.72 during trading hours on Friday, hitting $75.02. The company's stock had a trading volume of 911,396 shares, compared to its average volume of 1,187,082. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.28 and a current ratio of 0.28. Unum Group has a 12-month low of $45.23 and a 12-month high of $77.63. The business has a 50 day moving average price of $73.49 and a two-hundred day moving average price of $62.64. The company has a market cap of $13.70 billion, a PE ratio of 8.12, a PEG ratio of 0.97 and a beta of 0.81.

Unum Group (NYSE:UNM - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The financial services provider reported $2.13 earnings per share for the quarter, topping the consensus estimate of $2.10 by $0.03. The business had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.26 billion. Unum Group had a return on equity of 15.21% and a net margin of 13.76%. The firm's revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.94 EPS. Analysts expect that Unum Group will post 8.54 earnings per share for the current fiscal year.

Unum Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 24th will be issued a $0.42 dividend. The ex-dividend date is Friday, January 24th. This represents a $1.68 dividend on an annualized basis and a yield of 2.24%. Unum Group's dividend payout ratio is currently 18.18%.

Insiders Place Their Bets

In related news, EVP Elizabeth Claire Ahmed sold 5,000 shares of the stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $64.16, for a total transaction of $320,800.00. Following the sale, the executive vice president now owns 58,741 shares in the company, valued at approximately $3,768,822.56. This represents a 7.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Christopher W. Pyne sold 3,250 shares of Unum Group stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $70.02, for a total transaction of $227,565.00. Following the transaction, the executive vice president now directly owns 50,762 shares of the company's stock, valued at $3,554,355.24. The trade was a 6.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 107,914 shares of company stock worth $7,998,745 in the last 90 days. 0.93% of the stock is currently owned by corporate insiders.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.